SARS-CoV-2 antibody seroprevalence from past infection, by region, sex and age group
Description
Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.<br>
Resources
| Name |
Format |
Description |
Link |
| Dataset |
CSV |
|
https://www150.statcan.gc.ca/n1/tbl/csv/13100866-eng.zip |
| Dataset |
CSV |
|
https://www150.statcan.gc.ca/n1/tbl/csv/13100866-fra.zip |
| Dataset |
XML |
|
https://www150.statcan.gc.ca/n1/tbl/sdmx/13100866-SDMX.zip |
| Supporting Document |
HTML |
|
https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310086601 |
| Supporting Document |
HTML |
|
https://www150.statcan.gc.ca/t1/tbl1/fr/tv.action?pid=1310086601 |